137 related articles for article (PubMed ID: 38709246)
41. Tumor Microenvironment-Responsive Nanoparticles Amplifying STING Signaling Pathway for Cancer Immunotherapy.
Liu D; Liang S; Ma K; Meng QF; Li X; Wei J; Zhou M; Yun K; Pan Y; Rao L; Chen X; Wang Z
Adv Mater; 2024 Feb; 36(6):e2304845. PubMed ID: 37723642
[TBL] [Abstract][Full Text] [Related]
42. Cocktail strategy based on a dual function nanoparticle and immune activator for effective tumor suppressive.
Li Q; Chen Q; Yang X; Zhang Y; Lv L; Zhang Z; Zeng S; Lv J; Liu S; Fu B
J Nanobiotechnology; 2022 Feb; 20(1):84. PubMed ID: 35177088
[TBL] [Abstract][Full Text] [Related]
43. Novel Pt(IV) complex OAP2 induces STING activation and pyroptosis
Fan R; Lin R; Zhang S; Deng A; Hai Y; Zhuang J; Liu Y; Cheng M; Wei G
Acta Pharm Sin B; 2024 Apr; 14(4):1742-1758. PubMed ID: 38572099
[TBL] [Abstract][Full Text] [Related]
44. Sodium Bicarbonate Nanoparticles for Amplified Cancer Immunotherapy by Inducing Pyroptosis and Regulating Lactic Acid Metabolism.
Ding B; Zheng P; Tan J; Chen H; Meng Q; Li J; Li X; Han D; Li Z; Ma X; Ma P; Lin J
Angew Chem Int Ed Engl; 2023 Oct; 62(40):e202307706. PubMed ID: 37587061
[TBL] [Abstract][Full Text] [Related]
45. STING Activator c-di-GMP-Loaded Mesoporous Silica Nanoparticles Enhance Immunotherapy Against Breast Cancer.
Chen YP; Xu L; Tang TW; Chen CH; Zheng QH; Liu TP; Mou CY; Wu CH; Wu SH
ACS Appl Mater Interfaces; 2020 Dec; 12(51):56741-56752. PubMed ID: 33305564
[TBL] [Abstract][Full Text] [Related]
46. Genetically Edited Cascade Nanozymes for Cancer Immunotherapy.
Zhang J; Pan Y; Liu L; Xu Y; Zhao C; Liu W; Rao L
ACS Nano; 2024 May; 18(19):12295-12310. PubMed ID: 38695532
[TBL] [Abstract][Full Text] [Related]
47. Hyperbaric oxygen facilitates teniposide-induced cGAS-STING activation to enhance the antitumor efficacy of PD-1 antibody in HCC.
Li K; Gong Y; Qiu D; Tang H; Zhang J; Yuan Z; Huang Y; Qin Y; Ye L; Yang Y
J Immunother Cancer; 2022 Aug; 10(8):. PubMed ID: 36002188
[TBL] [Abstract][Full Text] [Related]
48. A manganese-phenolic network platform amplifying STING activation to potentiate MRI guided cancer chemo-/chemodynamic/immune therapy.
Pang X; Fu C; Chen J; Su M; Wei R; Wang Y; Lin W; Wei X; Jiang X; Yang X; Yang H; Wang J; Yang R
Biomater Sci; 2023 May; 11(11):3840-3850. PubMed ID: 37074080
[TBL] [Abstract][Full Text] [Related]
49. Nanoscale Metal-Organic Frameworks-Mediated Degradation of Mutant p53 Proteins and Activation of cGAS-STING Pathway for Enhanced Cancer Immunotherapy.
Sun L; Gao H; Wang H; Zhou J; Ji X; Jiao Y; Qin X; Ni D; Zheng X
Adv Sci (Weinh); 2024 Mar; 11(12):e2307278. PubMed ID: 38225693
[TBL] [Abstract][Full Text] [Related]
50. IFI16 promotes cervical cancer progression by upregulating PD-L1 in immunomicroenvironment through STING-TBK1-NF-kB pathway.
Cai H; Yan L; Liu N; Xu M; Cai H
Biomed Pharmacother; 2020 Mar; 123():109790. PubMed ID: 31896065
[TBL] [Abstract][Full Text] [Related]
51. Targeting STING elicits GSDMD-dependent pyroptosis and boosts anti-tumor immunity in renal cell carcinoma.
Wu S; Wang B; Li H; Wang H; Du S; Huang X; Fan Y; Gao Y; Gu L; Huang Q; Chen J; Zhang X; Huang Y; Ma X
Oncogene; 2024 May; 43(20):1534-1548. PubMed ID: 38548966
[TBL] [Abstract][Full Text] [Related]
52. IQGAP1 promotes mitochondrial damage and activation of the mtDNA sensor cGAS-STING pathway to induce endothelial cell pyroptosis leading to atherosclerosis.
An C; Sun F; Liu C; Huang S; Xu T; Zhang C; Ge S
Int Immunopharmacol; 2023 Oct; 123():110795. PubMed ID: 37597406
[TBL] [Abstract][Full Text] [Related]
53. Dual-Responsive Supramolecular Polymeric Nanomedicine for Self-Cascade Amplified Cancer Immunotherapy.
Hu W; Ye B; Yu G; Yang H; Wu H; Ding Y; Huang F; Wang W; Mao Z
Adv Sci (Weinh); 2024 May; 11(20):e2305382. PubMed ID: 38493499
[TBL] [Abstract][Full Text] [Related]
54. Responsive manganese-based nanoplatform amplifying cGAS-STING activation for immunotherapy.
He Q; Zheng R; Ma J; Zhao L; Shi Y; Qiu J
Biomater Res; 2023 Apr; 27(1):29. PubMed ID: 37061706
[TBL] [Abstract][Full Text] [Related]
55. CXCR4-Targeted Macrophage-Derived Biomimetic Hybrid Vesicle Nanoplatform for Enhanced Cancer Therapy through Codelivery of Manganese and Doxorubicin.
Jang Y; Cho YS; Kim A; Zhou X; Kim Y; Wan Z; Moon JJ; Park H
ACS Appl Mater Interfaces; 2024 Apr; 16(14):17129-17144. PubMed ID: 38533538
[TBL] [Abstract][Full Text] [Related]
56. Mn-phenolic networks as synergistic carrier for STING agonists in tumor immunotherapy.
Meng Y; Huang J; Ding J; Zhou H; Li Y; Zhou W
Mater Today Bio; 2024 Jun; 26():101018. PubMed ID: 38516172
[TBL] [Abstract][Full Text] [Related]
57. Microenvironment-Responsive Prodrug-Induced Pyroptosis Boosts Cancer Immunotherapy.
Xiao Y; Zhang T; Ma X; Yang QC; Yang LL; Yang SC; Liang M; Xu Z; Sun ZJ
Adv Sci (Weinh); 2021 Dec; 8(24):e2101840. PubMed ID: 34705343
[TBL] [Abstract][Full Text] [Related]
58. Remodeling of Tumor Microenvironment by Nanozyme Combined cGAS-STING Signaling Pathway Agonist for Enhancing Cancer Immunotherapy.
Dong W; Chen M; Chang C; Jiang T; Su L; Chen C; Zhang G
Int J Mol Sci; 2023 Sep; 24(18):. PubMed ID: 37762239
[TBL] [Abstract][Full Text] [Related]
59. Efficacy-shaping nanomedicine by loading Calcium Peroxide into Tumor Microenvironment-responsive Nanoparticles for the Antitumor Therapy of Prostate Cancer.
Wu D; Zhu ZQ; Tang HX; Shi ZE; Kang J; Liu Q; Qi J
Theranostics; 2020; 10(21):9808-9829. PubMed ID: 32863961
[No Abstract] [Full Text] [Related]
60. Gas therapy potentiates aggregation-induced emission luminogen-based photoimmunotherapy of poorly immunogenic tumors through cGAS-STING pathway activation.
Wang K; Li Y; Wang X; Zhang Z; Cao L; Fan X; Wan B; Liu F; Zhang X; He Z; Zhou Y; Wang D; Sun J; Chen X
Nat Commun; 2023 May; 14(1):2950. PubMed ID: 37221157
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
